Speaker illustration

Doctor Neha Pagidipati

Duke Clinical Research Institute, Durham (United States of America)

Neha J. Pagidipati, MD MPH is an Associate Professor of Medicine and cardiometabolic disease prevention specialist at the Duke Clinical Research Institute. She has been involved with cardiometabolic disease prevention research since 2011. Currently, her research focuses on clinical trials and implementation of evidence-based care of patients with high cardiovascular disease risk and lipid disorders, hypertension, diabetes, and/or obesity. Clinically, she directs the Duke Cardiometabolic Prevention Program, which focuses on behavior change and risk factor management in patients at high risk of cardiovascular and metabolic diseases.

Therapeutic implications: can we target adipose tissue to treat HFpEF

Event: ESC Congress 2025

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: The adipokine hypothesis and a new era in HFpEF science

Thumbnail

Ask the Trialists - KARDIA-3

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Ask the Trialists - KARDIA-3

Thumbnail

KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: HOT LINE 4

Thumbnail

Panel discussion.

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists

Thumbnail

Exploring the gap between data and clinical practice.

Event: ESC Congress 2020

Topic: Pharmacotherapy

Session: Discussing clinical implications of glucagon-like peptide-1 receptor agonists

Thumbnail

Risk prediction for ASCVD in primary prevention patients on statin therapy

Event: ESC Congress 2019

Topic: Cardiovascular Risk Assessment

Session: New approaches in risk stratification

Thumbnail

The association between obesity, diabetes control, and cardiovascular outcomes: insights from the TECOS trial

Event: ESC Congress 2017

Topic: Nutrition

Session: Impact of obesity on cardiovascular prognosis: new data

Thumbnail